FaceHeart App
Track your health trend on your smartphone with contactless vital signs
Company profile
Company profile
FaceHeart is a medical technology company that has developed FDA-cleared contactless video-based vital signs measurement software powered by AI image recognition technology. The company's flagship product, FaceHeart Vitals™, is the first video-based vital sign solution to receive US FDA 510(k) clearance as a Class II Software as Medical Device (SaMD), with clearances for both heart rate (K223622) and respiratory rate (K243966). Using remote photoplethysmography (rPPG) technology, FaceHeart analyzes subtle color changes in facial skin caused by blood circulation to measure key health metrics in real-time through a standard camera. The platform can measure 15+ health parameters including heart rate, respiratory rate, blood pressure, oxygen saturation, heart rate variability, atrial fibrillation detection, stress index, cardiovascular age, and various wellness indicators—all within a 50-second facial scan. FaceHeart serves multiple market segments including mobile health applications, insurance companies, telehealth providers, corporate wellness programs, and smart mirror manufacturers. The company's SDK can be integrated into smartphones, tablets, computers, smart home devices, and embedded boards, supporting both cloud-based and edge computing deployments. The technology is designed to work contactlessly from 30-150 cm away, allowing users to keep makeup and glasses on during measurements. With validation backed by 20+ clinical trials and 300M+ data points, FaceHeart aims to democratize healthcare access by enabling anyone, anywhere to access vital health insights through everyday devices.
Company description FaceHeart official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Api Only · Cloud Saas · Embedded deployment with recorded integration context.
Recorded integration context: FHIR-formatted data output for healthcare system integration.
Company milestones
First FDA-cleared contactless video-based vital sign solution; FDA 510(k) clearances obtained for heart rate (K223622) and respiratory rate (K243966); First company in Peru and Latin America to deploy FDA-cleared AI vital signs technology; Partnership with Emagine Solutions for maternal health monitoring
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Track your health trend on your smartphone with contactless vital signs
Check your heart with just a glance through smart mirror technology
FDA-cleared contactless vital signs measurement SDK powered by AI image recognition
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
No linked records are currently available.
Regulatory
K223622 · 510k · Sep 1, 2023
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Heart rate and respiratory rate measurements validated for clinical use
Comprehensive health assessment from single 50-second scan
No wearables or physical contact required, 30-150 cm distance
AI-driven contactless vital sign measurement for health monitoring of employees in human resource management, identifying health indicators that impact productivity
Enabled proactive health management for stable growth and operational efficiency
Integrating FaceHeart into The Journey Pregnancy app to enable patients to track blood pressure trends digitally without equipment, helping assess propensity for preeclampsia and hypertensive conditions
Closed access gap in maternal health for patients without home blood pressure monitoring equipment
First company in Peru and Latin America to utilize FDA-cleared AI technology for contactless vital signs, driving innovative solutions to democratize healthcare across the region
Enhanced quality of care and advanced telemedicine throughout Latin America
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on FaceHeart's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.